RCE in Genexis Platinum 4410

CVE-2021-29003

Genexis PLATINUM 4410 2.1 P4410-V2-1.28 devices allow remote attackers to execute arbitrary code via shell metacharacters to sys_config_valid.xgi, as demonstrated by the sys_config_valid.xgi?exeshell=%60telnetd%20%26%60 URI.

Vulnerability class: Command Injection (OS Command Injection)

Published · last modified .

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.454 (98.8th percentile), scored .

Moderate probability of exploitation in the next 30 days — watch for active exploitation reports. 99th percentile — 98.8% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2021-29003: held from 0.454 to 0.454.

EPSS over last 30 days · oldest: 0.454 · newest: 0.454 · change: 0.000

Affected products

Weakness classification (CWE)

Public proof-of-concept exploits

References

Frequently asked questions

What is CVE-2021-29003?
CVE-2021-29003 is a critical-severity vulnerability in Genexis Platinum 4410, classified under OS Command Injection. CVSS score: 9.8/10. Published 2021-04-13.
How severe is CVE-2021-29003?
Critical severity. CVSS v3 base score is 9.8 out of 10.
Is CVE-2021-29003 known to be exploited?
8 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.